Cytotoxic Effects of Phosphonate-Functionalized Mesoporous Silica Nanoparticles

ACS Applied Materials and Interfaces

Volumn 8, Issue 3, 2016, Pages 2416-2422

  Menon, Nandita ^a   Leong, David T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

anticancer drugs; BJ cells; cell cycle; MCF 7 cells; mesoporous silica nanoparticles; phosphonate groups

Indexed keywords

CELL CULTURE; CELL DEATH; CELLS; CYTOTOXICITY; MESOPOROUS MATERIALS; NANOPARTICLES; SILICA; SYNTHESIS (CHEMICAL);

ANTICANCER DRUG; CELL CYCLE; MCF-7 CELLS; MESOPOROUS SILICA NANOPARTICLES; PHOSPHONATE GROUP;

CYTOLOGY;

NANOPARTICLE; PHOSPHONIC ACID DERIVATIVE; SILICON DIOXIDE;

CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; HYDRODYNAMICS; MCF-7 CELL LINE; PARTICLE SIZE; POROSITY; STATIC ELECTRICITY; ULTRASTRUCTURE;

CELL DEATH; CELL SURVIVAL; HUMANS; HYDRODYNAMICS; MCF-7 CELLS; NANOPARTICLES; ORGANOPHOSPHONATES; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; STATIC ELECTRICITY;

EID: 84961363754     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b11741     Document Type: Article

References (50)

1. Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2015 Ca-Cancer J. Clin. 2015, 65, 5-29 10.3322/caac.21254
2. Hubbell, J. A.; Chilkoti, A. Nanomaterials for Drug Delivery Science 2012, 337, 303-305 10.1126/science.1219657
3. Wong, H. L.; Bendayan, R.; Rauth, A. M.; Li, Y.; Wu, X. Y. Chemotherapy with Anticancer Drugs Encapsulated in Solid Lipid Nanoparticles Adv. Drug Delivery Rev. 2007, 59, 491-504 10.1016/j.addr.2007.04.008
4. Lu, J.; Liong, M.; Zink, J. I.; Tamanoi, F. Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs Small 2007, 3, 1341-1346 10.1002/smll.200700005
5. Fukuda, M.; Yamaguchi, S.; Ohta, T.; Nakayama, Y.; Ogata, H.; Shimizu, K.; Nishikawa, T.; Adachi, Y.; Fukuma, E. Combination Therapy for Advanced Breast Cancer: Cyclophosphamide, Doxorubicin, UFT, and Tamoxifen Oncology 1999, 13, 77-81
6. Jin, Y.; Yue, X.; Zhang, Q.; Wu, X.; Cao, Z.; Dai, Z. Cerasomal Doxorubicin with Long-Term Storage Stability and Controllable Sustained Release Acta Biomater. 2012, 8, 3372-3380 10.1016/j.actbio.2012.05.022
7. Szepeshazi, K.; Schally, A. V.; Block, N. L.; Halmos, G.; Nadji, M.; Szalontay, L.; Vidaurre, I.; Abi-Chaker, A.; Rick, F. G. Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH Analog AEZS-108 Oncotarget 2013, 4, 751-760 10.18632/oncotarget.1044
8. Buzea, C.; Pacheco, I. I.; Robbie, K. Nanomaterials and Nanoparticles: Sources and Toxicity Biointerphases 2007, 2, MR17-MR172 10.1116/1.2815690
9. Ding, F.; Deng, H.; Du, Y.; Shi, X.; Wang, Q. Emerging Chitin and Chitosan Nanofibrous Materials for Biomedical Applications Nanoscale 2014, 6, 9477-9493 10.1039/C4NR02814G
10. Zhang, Z.; Wang, L.; Wang, J.; Jiang, X.; Li, X.; Hu, Z.; Ji, Y.; Wu, X.; Chen, C. Mesoporous Silica-Coated Gold Nanorods as a Light-Mediated Multifunctional Theranostic Platform for Cancer Treatment Adv. Mater. 2012, 24, 1418-1423 10.1002/adma.201104714
11. Xu, A.; Yao, M.; Xu, G.; Ying, J.; Ma, W.; Li, B.; Jin, Y. A Physical Model for the Size-dependent Cellular Uptake of Nanoparticles Modified with Cationic Surfactants Int. J. Nanomed. 2012, 7, 3547-3554 10.2147/IJN.S32188
12. Zhang, S.; Li, J.; Lykotrafitis, G.; Bao, G.; Suresh, S. Size-Dependent Endocytosis of Nanoparticles Adv. Mater. 2009, 21, 419-424 10.1002/adma.200801393
13. Karmakar, A.; Zhang, Q.; Zhang, Y. Neurotoxicity of Nanoscale Materials J. Food Drug Anal. 2014, 22, 147-160 10.1016/j.jfda.2014.01.012
14. Xu, X.; Sabanayagam, C. R.; Harrington, D. A.; Farach-Carson, M. C.; Jia, X. A Hydrogel-Based Tumor Model for the Evaluation of Nanoparticle-Based Cancer Therapeutics Biomaterials 2014, 35, 3319-3330 10.1016/j.biomaterials.2013.12.080
15. Setyawati, M. I.; Tay, C. Y.; Docter, D.; Stauber, R. H.; Leong, D. T. Understanding and Exploiting Nanoparticles' Intimacy with the Blood Vessel and Blood Chem. Soc. Rev. 2015, 44, 8174-8199 10.1039/C5CS00499C
16. Setyawati, M. I.; Mochalin, V. N.; Leong, D. T. Tuning Endothelial Permeability with Functionalized Nanodiamonds ACS Nano 2015, 10.1021/acsnano.5b06487
17. Tay, C. Y.; Setyawati, M. I.; Xie, J.; Parak, W. J.; Leong, D. T. Back to Basics: Exploiting the Innate Physico-chemical Characteristics of Nanomaterials for Biomedical Applications Adv. Funct. Mater. 2014, 24, 5936-5955 10.1002/adfm.201401664
18. Roduner, E. Size Matters: Why Nanomaterials are Different Chem. Soc. Rev. 2006, 35, 583-592 10.1039/b502142c
19. Guo, C.; Smith, R.; Gant, T. W.; Leonard, M. O. Cerium Dioxide Nanoparticles Protect Against Oxidative Stress Induced Injury Through Modulation of TGF-β Signalling Toxicol. Res. 2015, 4, 464-475 10.1039/C4TX00210E
20. Tan, G. R.; Feng, S. S.; Leong, D. T. The Reduction of Anti-Cancer Drug Antagonism by the Spatial Protection of Drugs with PLA-TPGS Nanoparticles Biomaterials 2014, 35, 3044-3051 10.1016/j.biomaterials.2013.12.033
21. Kutty, R. V.; Leong, D. T.; Feng, S. S. Nanomedicine for Treatment of Triple Negative Breast Cancer Nanomedicine 2014, 9, 561-564 10.2217/nnm.14.19
22. Xie, W.; Qiu, P.; Mao, C. Bio-Imaging, Detection and Analysis by Using Nanostructures as SERS Substrates J. Mater. Chem. 2011, 21, 5190-5202 10.1039/c0jm03301d
23. Setyawati, M. I.; Tay, C. Y.; Chia, S. L.; Goh, S. L.; Fang, W.; Neo, M. J.; Chong, H. C.; Tan, S. M.; Loo, S. C. J.; Ng, K. W.; Xie, J. P.; Ong, C. N.; Tan, N. S.; Leong, D. T. Titanium Dioxide Nanomaterials Cause Endothelial Cell Leakiness by Disrupting the Homophilic Interaction of VE-Cadherin Nat. Commun. 2013, 4, 1673 10.1038/ncomms2655
24. Setyawati, M. I.; Tay, C. Y.; Leong, D. T. Effect of Zinc Oxide Nanomaterials-Induced Oxidative Stress on the p53 Pathway Biomaterials 2013, 34, 10133-10142 10.1016/j.biomaterials.2013.09.024
25. 10-12 Nanomolecules for High Tumor Specificity and Cancer Radiotherapy Adv. Mater. 2014, 26, 4565-4568 10.1002/adma.201400866
26. Zhao, Q.; Liu, J.; Zhu, W.; Sun, C.; Di, D.; Zhang, Y.; Wang, P.; Wang, Z.; Wang, S. Dual-Stimuli Responsive Hyaluronic Acid-Conjugated Mesoporous Silica for Targeted Delivery to CD44-Overexpressing Cancer Cells Acta Biomater. 2015, 23, 147-156 10.1016/j.actbio.2015.05.010
27. Zou, Z.; He, X.; He, D.; Wang, K.; Qing, Z.; Yang, X.; Wen, L.; Xiong, J.; Li, L.; Cai, L. Programmed Packaging of Mesoporous Silica Nanocarriers for Matrix Metalloprotease 2-Triggered Tumor Targeting and Release Biomaterials 2015, 58, 35-45 10.1016/j.biomaterials.2015.04.034
28. Chen, W. H.; Luo, G. F.; Lei, Q.; Jia, H. Z.; Hong, S.; Wang, Q. R.; Zhuo, R. X.; Zhang, X. Z. MMP-2 Responsive Polymeric Micelles for Cancer-Targeted Intracellular Drug Delivery Chem. Commun. 2015, 51, 465-468 10.1039/C4CC07563C
29. Gao, W.; Xiang, B.; Meng, T.; Liu, F.; Qi, X. Chemotherapeutic Drug Delivery to Cancer Cells Using a Combination of Folate Targeting and Tumor Microenvironment Sensitive Polypeptides Biomaterials 2013, 34, 4137-4149 10.1016/j.biomaterials.2013.02.014
30. Wang, X.; Teng, Z.; Wang, H.; Wang, C.; Liu, Y.; Tang, Y.; Wu, J.; Sun, J.; Wang, H.; Wang, J.; Lu, G. Increasing the Cytotoxicity of Doxorubicin in Breast Cancer MCF-7 Cells with Multidrug Resistance Using a Mesoporous Silica Nanoparticle Drug Delivery System Int. J. Clin. Exp. Pathol. 2014, 7, 1337-1347
31. Rim, H. P.; Min, K. H.; Lee, H. J.; Jeong, S. Y. pH-Tunable Calcium Phosphate Covered Mesoporous Silica Nanocontainers for Intracellular Controlled Release of Guest Drugs Angew. Chem., Int. Ed. 2011, 50, 8853-8857 10.1002/anie.201101536
32. Li, L. L.; Yin, Q.; Cheng, J.; Lu, Y. Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells Adv. Healthcare Mater. 2012, 1, 567-572 10.1002/adhm.201200116
33. Kalluri, R.; Zeisberg, M. Fibroblasts in Cancer Nat. Rev. Cancer 2006, 6, 392-401 10.1038/nrc1877
34. Yu, M.; Zhou, L.; Zhang, J.; Yuan, P.; Thorn, P.; Gu, W.; Yu, C. A Simple Approach to Prepare Monodisperse Mesoporous Silica Nanospheres with Adjustable Sizes J. Colloid Interface Sci. 2012, 376, 67-75 10.1016/j.jcis.2012.03.014
35. Wang, Y.; Wang, K.; Yan, X.; Huang, R. A General Strategy for Dual-Triggered Combined Tumor Therapy Based on Template Semi-Graphatized Mesoporous Silica Nanoparticles Adv. Healthcare Mater. 2014, 3, 485-489 10.1002/adhm.201300324
36. Yang, K. N.; Zhang, C. Q.; Wang, W.; Wang, P. C.; Zhou, J. P.; Liang, X. J. pH-Responsive Mesoporous Silica Nanoparticles Employed in Controlled Drug Delivery Systems for Cancer Treatment Cancer Biol. Med. 2014, 11, 34-43
37. Jia, L.; Shen, J.; Li, Z.; Zhang, D.; Zhang, Q.; Duan, C.; Liu, G.; Zheng, D.; Liu, Y.; Tian, X. Successfully Tailoring the Pore Size of Mesoporous Silica Nanoparticles: Exploitation of Delivery Systems for Poorly Water-Soluble Drugs Int. J. Pharm. 2012, 439, 81-91 10.1016/j.ijpharm.2012.10.011
38. Asefa, T.; Tao, Z. Biocompatibility of Mesoporous Silica Nanoparticles Chem. Res. Toxicol. 2012, 25, 2265-2284 10.1021/tx300166u
39. Lynch, I.; Dawson, K. A. Protein-Nanoparticle Interactions Nano Today 2008, 3, 40-47 10.1016/S1748-0132(08)70014-8
40. Tay, C. Y.; Fang, W.; Setyawati, M. I.; Sum, C. P.; Chen, X.; Hong, C. H. L.; Leong, D. T. Reciprocal Response of Human Oral Epithelial Cells to Internalized Silica Nanoparticles Part. Part. Syst. Charact. 2013, 30, 784-793 10.1002/ppsc.201300111
41. 2 Nanoparticles in Cell Culture Media Environ. Sci. Technol. 2010, 44, 7309-7314 10.1021/es100417s
42. Horie, M.; Nishio, K.; Fujita, K.; Endoh, S.; Miyauchi, A.; Saito, Y.; Iwahashi, H.; Yamamoto, K.; Murayama, H.; Nakano, H.; Nanashima, N.; Niki, E.; Yoshida, Y. Protein Adsorption of Ultrafine Metal Oxide and its Influence on Cytotoxicity Toward Cultured Cells Chem. Res. Toxicol. 2009, 22, 543-553 10.1021/tx800289z
43. Kutty, R. V.; Feng, S. S. Cetuximab Conjugated Vitamin E TPGS Micelles for Targeted Delivery of Docetaxel for Treatment of Triple Negative Breast Cancers Biomaterials 2013, 34, 10160-10171 10.1016/j.biomaterials.2013.09.043
44. Tang, F.; Li, L.; Chen, D. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery Adv. Mater. 2012, 24, 1504-1534 10.1002/adma.201104763
45. Abbas, T.; Dutta, A. p21 in Cancer: Intricate Networks and Multiple Activities Nat. Rev. Cancer 2009, 9, 400-414 10.1038/nrc2657
46. Yip, K. W.; Reed, J. C. Bcl-2 Family Proteins and Cancer Oncogene 2008, 27, 6398-6406 10.1038/onc.2008.307
47. Croft, M. The Role of TNF Superfamily Members in T-Cell Function and Diseases Nat. Rev. Immunol. 2009, 9, 271-285 10.1038/nri2526
48. Ahmed, M.; Rahman, N. ATM and Breast Cancer Susceptibility Oncogene 2006, 25, 5906-5911 10.1038/sj.onc.1209873
49. Gorospe, M.; Liu, Y.; Xu, Q.; Chrest, F. J.; Holbrook, N. J. Inhibition of G1 Cyclin-Dependent Kinase Activity during Growth Arrest of Human Breast Carcinoma Cells by Prostaglandin A2 Mol. Cell. Biol. 1996, 16, 762-770 10.1128/MCB.16.3.762
50. Duursma, A.; Agami, R. p53-Dependent Regulation of Cdc6 Protein Stability Controls Cellular Proliferation Mol. Cell. Biol. 2005, 25, 6937-6947 10.1128/MCB.25.16.6937-6947.2005